Assessment and Correlation of Adverse Events Following Coronavirus Disease Vaccination with Blood Group and Dietary Style

Abstract

Objectives: The objective of this study is to assess and correlate adverse drug events following coronavirus disease (COVID) vaccination with blood group and dietary style. Methodology: This is a cross-sectional study carried out from May 2021 to July 2021. A prevalidated Google questionnaire containing demographic details, dietary style, blood group, preexisting diseases, and adverse events of the COVID vaccine was circulated to all health-care professionals of our institution through mail/WhatsApp. Informed consent was obtained (in Google Forms) from all the participants after describing the purpose of the study and the assurance to maintain anonymity and confidentiality. A total of 102 responses were collected, out of which 100 (n = 100) responses were analyzed and interpreted (two responses were excluded since participants are not vaccinated). The descriptive statistical method is applied for the assessment of adverse events. The Chi-square test is applied to assess the correlation between adverse events with blood group and dietary style. P 0.05). Conclusion: The present study concludes that study participants experienced minor adverse events following Covishield and Covaxin; pain at the injection site, myalgia, and fever are more frequent. Moreover, there is a higher incidence of injection site pain in nonvegetarians compared to vegetarians. However, there is no significant association between other adverse events with blood group and dietary style of the participants.

Keywords

• blood group
• coronavirus disease vaccination
• covaxin
• covishield
• dietary style